DALAGIS FOAM
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CLINDAMYCIN PHOSPHATE
Available from:
PADAGIS ISRAEL AGENCIES LTD, ISRAEL
ATC code:
D10AF01
Pharmaceutical form:
FOAM
Composition:
CLINDAMYCIN PHOSPHATE 1 %
Administration route:
TOPICAL
Prescription type:
Required
Manufactured by:
PADAGIS ISRAEL PHARMACEUTICALS LTD, ISRAEL
Therapeutic area:
CLINDAMYCIN
Therapeutic indications:
Dalagis Foam is indicated for the topical treatment of mild to moderate acne vulgaris in adults and children 12 years and older.
Authorization date:
2018-02-11
